Broad spectrum anthelminthic for recreational horses
Active substances: Albendazole 7 g/100 ml (1.4 g/20 ml syringe or 3.5 g/50 ml syringe); Avermectin B1 0.2 g/100 ml (40 mg/20 ml syringe or 0.1 g/50 ml syringe)
Excipients: carboxymethylcellulose, benzoic acid, Tween 80, ethanol, distilled water
Ecvirom is an antiparasitic product which contains albendazole and avermectin. Ecvirom acts on parasites by inhibiting the mitochondrial oxidoreductases; thus the amount of ATP generated by mitochondrion is destroyed. As a result, the entire energetic metabolism of parasite is blocked. The parasite dies within 24-48 hours because of complete energy lost.
Albendazole is active against worms, regardless of their localization (respiratory or gastrointestinal tract, liver).
Avermectin acts on CNS of roundworms producing paralysis by GABA mediated synaptic inhibition; as a result the nerve influx is interrupted.
Toxicity of Ecvirom is low and maximum doses are well tolerated. Due to the combined effects of both substances, parasite resistance is extremely rare.
Ecvirom is recommended for control of endo- and ectoparasitosis in horses, as follows:
- trematodosis induced by Fasciolla hepatica;
- cestodosis caused by Anoplocephala genus;
- nematodosis induced by Parascaris equorum, Strongylus spp., Trichonema spp., Strongyloides spp., Habronema spp., Oxyuris equi, Gongylonema spp., Parafilaria spp., Onchocerca spp., Dictyocaulus arnfieldi, Trichinella spiralis.
- arachnosis: linguatulosis (Linguatulosa serrata); horse`s scabies (Sarcoptes scabiei var. equi, Psoroptes communis var. equi, Chorioptes bovis var. equi).
- entomosis induced by Gastrophilus spp., Hypoderma spp.
Do not use in animals whose meat is intended for human consumption.
Do not use in animals sensitive to the active substances from the product’s composition.
None known when comply with the recommended doses.
METHOD OF ADMINISTRATION
The product is administered orally, by syringe. The usual dose for preventive and curative treatment is 10 ml/100 kg body weight for both adult animals and foals, as a sole dose. The foals should be first treated at the age of 6-8 weeks. Animals (young and adult animals) should be disinfected quarterly. The product may be administered any time of the day.
Comply with the basic procedures for immobilization of the horse.
The usual treatments should be applied quarterly.
Comply with the treatment schedule and the recommended doses.
Before administration, make sure that the horse’s mouth contains no feed.
The product should be orally administered in the corner; the tongue of the animal should not be immobilized during the administration, but let free.
PRESENTATION FORM: 20 or 50 ml plastic syringes labeled and secondary packaged in cardboard boxes as follows: 2 x 20 ml syringes or one 50 ml syringe.